ProCE Banner Activity

Integrating New Data From CROI 2023


Download slides to review expert insights on the most clinically relevant data presented at CROI 2023, as well as other key studies that may be significant to the advancement of HIV patient care. 

Released: March 17, 2023

Expiration: March 15, 2024



Princy N. Kumar

Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Jeffrey Kwong


Professor, Division of Advanced Nursing Practice
Rutgers, The State University of New Jersey
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Milena Murray

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP

Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Joseph J. Eron, Jr.

Joseph J. Eron, Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

ProCE Banner


Supported by an educational grant from Viiv Healthcare

ViiV Healthcare

Faculty Disclosure

Princy N. Kumar, MD, FIDSA, MACP: consultant/advisor/speaker: Gilead Sciences, Johnson & Johnson, Merck, Theratechnologies, ViiV; researcher: American Gene Technologies, Gilead Sciences, GlaxoSmithKline, Merck; stock/stock options: Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS, has no relevant financial relationships to disclose.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCPconsultant/advisor/speaker: Gilead Sciences, Janssen, Merck, ViiV Healthcare.

Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, GSK, Janssen, Merck, ViiV Healthcare; researcher: Gilead Sciences, ViiV Healthcare.